These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 12710291)

  • 41. Secondary prevention after acute myocardial infarction and coronary revascularisation: focus on Angiotensin converting enzyme inhibitors.
    Kaski JC; Fernandez-Berges D
    Cardiovasc Drugs Ther; 2008 Jun; 22(3):185-91. PubMed ID: 18317916
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pharmacotherapy after cardiac infarction].
    Darius H; Meyer J
    Internist (Berl); 2001 May; 42(5):699-712. PubMed ID: 11400577
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacologic therapies after myocardial infarction.
    Rapaport E; Gheorghiade M
    Am J Med; 1996 Oct; 101(4A):4A61S-69S; discussion 4A69S-70S. PubMed ID: 8900339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Practical algorithms for pharmacologic management of the post myocardial infarction patient.
    Reiffel JA; ;
    Clin Cardiol; 2005 Nov; 28(11 Suppl 1):I28-37. PubMed ID: 16450810
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Burden and Prevention of Adverse Cardiac Events in Patients with Concomitant Chronic Heart Failure and Coronary Artery Disease: A Literature Review.
    Lavoie L; Khoury H; Welner S; Briere JB
    Cardiovasc Ther; 2016 Jun; 34(3):152-60. PubMed ID: 26915344
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peripheral arterial disease: Pathophysiology, risk factors, diagnosis, treatment, and prevention.
    Muir RL
    J Vasc Nurs; 2009 Jun; 27(2):26-30. PubMed ID: 19486852
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antithrombotic drugs in the prevention of ischemic stroke].
    Bousser MG
    J Mal Vasc; 2005 Dec; 30(5):267-79. PubMed ID: 16439939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent developments in secondary prevention and cardiac rehabilitation after acute myocardial infarction.
    Dalal H; Evans PH; Campbell JL
    BMJ; 2004 Mar; 328(7441):693-7. PubMed ID: 15031243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Secondary prevention after myocardial infarction].
    Pflumm JE; Pomykaj T; Heintzen MP
    Internist (Berl); 2008 Sep; 49(9):1052-60. PubMed ID: 18651118
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stroke prevention: what's new?
    Gerraty RP
    Intern Med J; 2003 Apr; 33(4):177-81. PubMed ID: 12680984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Medical management of cervical arterial dissections].
    Vuillier F; Tatu L; Moulin T
    J Neuroradiol; 2002 Dec; 29(4):265-70. PubMed ID: 12538944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current strategies for ischemic stroke prevention: role of multimodal combination therapies.
    Alberts MJ; Ovbiagele B
    J Neurol; 2007 Oct; 254(10):1414-26. PubMed ID: 17934879
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Discharge prescription for ischemic stroke patients].
    Rosolacci T; Neuville V
    Rev Neurol (Paris); 2005 Jul; 161(6-7):738-44. PubMed ID: 16141975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Associations between peripheral artery disease and ischemic stroke: implications for primary and secondary prevention.
    Banerjee A; Fowkes FG; Rothwell PM
    Stroke; 2010 Sep; 41(9):2102-7. PubMed ID: 20689082
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Long-term management of coronary patients: current guidelines and practices].
    Bauters C
    Am J Cardiovasc Drugs; 2007; 7 Spec No 1():1-4. PubMed ID: 19839180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antithrombotic therapy in diabetes: which, when, and for how long?
    Ajjan RA; Kietsiriroje N; Badimon L; Vilahur G; Gorog DA; Angiolillo DJ; Russell DA; Rocca B; Storey RF
    Eur Heart J; 2021 Jun; 42(23):2235-2259. PubMed ID: 33764414
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Secondary prevention of atherothrombotic events after ischemic stroke.
    Adams HP
    Mayo Clin Proc; 2009; 84(1):43-51. PubMed ID: 19121254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Revisiting secondary prevention in coronary heart disease.
    Sigamani A; Gupta R
    Indian Heart J; 2022; 74(6):431-440. PubMed ID: 36455667
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions.
    Canonico ME; Piccolo R; Avvedimento M; Leone A; Esposito S; Franzone A; Giugliano G; Gargiulo G; Hess CN; Berkowitz SD; Hsia J; Cirillo P; Esposito G; Bonaca MP
    J Cardiovasc Dev Dis; 2023 Apr; 10(4):. PubMed ID: 37103043
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence, clinical significance, and management of peripheral arterial disease in women: is there a role for postmenopausal hormone therapy?
    Mazhari R; Hsia J
    Vasc Health Risk Manag; 2005; 1(2):111-7. PubMed ID: 17315397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.